← Back to Clinical Trials
Recruiting NCT06956833

NCT06956833 Immersive Virtual Reality Simulation-Effects of Self-Guided Versus Facilitator-Guided Debriefing

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06956833
Status Recruiting
Phase
Sponsor Rigshospitalet, Denmark
Condition Virtual Reality Simulation
Study Type INTERVENTIONAL
Enrollment 88 participants
Start Date 2025-05-06
Primary Completion 2025-10

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Ìmmersive virtual reality simulation with self-guided debriefingÌmmersive virtual reality simulation with facilitator-guided debriefing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 88 participants in total. It began in 2025-05-06 with a primary completion date of 2025-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to find out whether self-guided and facilitator-guided virtual reality (VR) simulations are equally effective in helping medical students learn how to manage and treat critically ill children. The study will also investigate how medical students feel about the two training methods and examine how many experience cybersickness. The main questions it aims to answer are: * Does self-guided VR simulation work as well as facilitator-guided VR simulation in teaching medical students how to manage critically ill children? * How do medical students experience the ease of use, workload, reflection on learning, and motivation in each training method? * How many students experience cybersickness? To answer these questions, researchers will compare the two training methods to evaluate if self-guided VR simulation is an effective way to teach medical students how to manage critically ill children. Participants will: * Work through three VR cases to practice managing critically ill children in a safe environment. * Be tested before and after the VR simulation to assess changes in their skills managing critically ill children. * Complete surveys about their experience of the VR simulation, the training sessions, and any cybersickness symptoms they might have.

Eligibility Criteria

Inclusion Criteria: * Eligible participants will be medical students enrolled at medical schools in Denmark who are within two years of graduation. Exclusion Criteria: * Lack of informed consent

Contact & Investigator

Central Contact

Amalie M Andersen, MD, PhD student

✉ amalie.middelboe.andersen@regionh.dk

📞 25344610

Frequently Asked Questions

Who can join the NCT06956833 clinical trial?

This trial is open to participants of all sexes, studying Virtual Reality Simulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06956833 currently recruiting?

Yes, NCT06956833 is actively recruiting participants. Contact the research team at amalie.middelboe.andersen@regionh.dk for enrollment information.

Where is the NCT06956833 trial being conducted?

This trial is being conducted at Copenhagen, Denmark.

Who is sponsoring the NCT06956833 clinical trial?

NCT06956833 is sponsored by Rigshospitalet, Denmark. The trial plans to enroll 88 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology